Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network
- PMID: 28638844
- PMCID: PMC5473366
- DOI: 10.1093/ofid/ofx086
Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network
Abstract
Background: Outpatient parenteral antimicrobial therapy (OPAT) prescribing has increased along with the trend toward early discharge of hospitalized patients who have infections. There is limited literature that assesses unplanned hospitalizations during OPAT. This study aims to elucidate the predictors of unplanned hospitalization in OPAT patients after discharge from acute-care facilities within Carolinas HealthCare System (CHS). Understanding these predictors may inform future interventions to improve treatment efficacy and patient outcomes.
Methods: The study cohort included hospitalized patients aged >19 years who initiated OPAT in an acute-care facility within CHS in 2014-2015. Patients who had OPAT prescribed at an ambulatory-care facility were excluded. The primary outcome was unplanned hospitalization anytime during the at-risk time from discharge through 90 days.
Results: The unplanned hospitalization rate for the cohort was 18.5%. In adjusted analysis, having OPAT delivered at a skilled nursing facility was associated with a 46% (incident risk ratio = 1.46; 95% confidence interval = 1.04-2.06) increased risk of an unplanned hospitalization compared with patients receiving OPAT at home after adjustment for demographics, comorbidities, indication, treatment duration, and antimicrobial prescribed. Infusion, dialysis, and rehabilitation centers had the lowest rates of unplanned hospitalizations.
Conclusions: These results suggest that the location of OPAT delivery is associated with unplanned hospitalizations and that older patients need additional support during OPAT.
Keywords: antimicrobial; hospitalization; infusion; outpatient parenteral antimicrobial therapy (OPAT)..
Figures
Similar articles
-
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug. PLOS Digit Health. 2023. PMID: 37531342 Free PMC article.
-
Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.Clin Microbiol Infect. 2019 Jul;25(7):905.e1-905.e7. doi: 10.1016/j.cmi.2018.11.009. Epub 2018 Nov 28. Clin Microbiol Infect. 2019. PMID: 30502491
-
An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.Ther Adv Infect Dis. 2023 Sep 1;10:20499361231195966. doi: 10.1177/20499361231195966. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37667754 Free PMC article.
-
Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?Infection. 2019 Apr;47(2):169-181. doi: 10.1007/s15010-018-1250-1. Epub 2018 Nov 15. Infection. 2019. PMID: 30443780 Review.
-
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23. J Antimicrob Chemother. 2015. PMID: 25538169 Review.
Cited by
-
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic.Open Forum Infect Dis. 2020 Jul 21;7(8):ofaa309. doi: 10.1093/ofid/ofaa309. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32782914 Free PMC article.
-
Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections.Infect Dis Ther. 2019 Jun;8(2):171-184. doi: 10.1007/s40121-019-0247-0. Epub 2019 May 3. Infect Dis Ther. 2019. PMID: 31054088 Free PMC article.
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study.Antimicrob Steward Healthc Epidemiol. 2022 Nov 11;2(1):e183. doi: 10.1017/ash.2022.313. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36406163 Free PMC article.
-
Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis.Antimicrob Steward Healthc Epidemiol. 2023 Oct 19;3(1):e169. doi: 10.1017/ash.2023.458. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38028929 Free PMC article.
References
-
- Tice AD, Rehm SJ, Dalovisio JR et al. ; IDSA Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38:1651–72. - PubMed
-
- Chapman AL, Dixon S, Andrews D et al. . Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64:1316–24. - PubMed
-
- Candel FJ, Julian-Jimenez A, Gonzalez-Del Castillo J. Current status in outpatient parenteral antimicrobial therapy: a practical view. Rev Esp Quimioter. 2016; 29:55–68. - PubMed
-
- MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents. 2014;43:7–16. - PubMed
-
- Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51suppl 2:S198–208. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources